Zimmer Biomet Holdings Inc
ZBH90.805USD
+0.275+0.30%
Cierre 12/30, 16:00（ET）Cotizaciones retrasadas 15 min
18.00BCap. mercado
22.40P/E TTM
Más Datos de Zimmer Biomet Holdings Inc Compañía
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Información de Zimmer Biomet Holdings Inc
Símbolo de cotizaciónZBH
Nombre de la empresaZimmer Biomet Holdings Inc
Fecha de salida a bolsaJul 25, 2001
Director ejecutivoTornos (Ivan)
Número de empleados17000
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 25
Dirección345 E Main St
CiudadWARSAW
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46580-2746
Teléfono15742676131
Sitio Webhttps://www.zimmerbiomet.com/en
Símbolo de cotizaciónZBH
Fecha de salida a bolsaJul 25, 2001
Director ejecutivoTornos (Ivan)
Ejecutivos de Zimmer Biomet Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
3.42K
+34.66%
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.17B
56.51%
International
903.50M
43.49%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
Otro
59.19%
Accionistas
Accionistas
Proporción
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
Otro
59.19%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
54.12%
Investment Advisor/Hedge Fund
37.70%
Hedge Fund
2.18%
Pension Fund
2.06%
Research Firm
1.73%
Bank and Trust
1.28%
Sovereign Wealth Fund
1.27%
Individual Investor
0.13%
Family Office
0.07%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1945
195.45M
98.66%
-607.37K
2025Q2
1996
190.39M
96.22%
-5.04M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dodge & Cox
22.10M
11.15%
+2.01M
+10.01%
Jun 30, 2025
The Vanguard Group, Inc.
23.16M
11.69%
+196.58K
+0.86%
Jun 30, 2025
T. Rowe Price Associates, Inc.
14.50M
7.32%
+336.36K
+2.37%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.93M
5.52%
-195.19K
-1.75%
Jun 30, 2025
State Street Investment Management (US)
8.75M
4.42%
-6.59K
-0.08%
Jun 30, 2025
Capital International Investors
6.77M
3.42%
+6.77M
--
Jun 30, 2025
Geode Capital Management, L.L.C.
5.12M
2.59%
+69.48K
+1.37%
Jun 30, 2025
American Century Investment Management, Inc.
5.71M
2.88%
+458.90K
+8.74%
Jun 30, 2025
Harris Associates L.P.
3.73M
1.88%
+3.73M
--
Jun 30, 2025
PRIMECAP Management Company
4.71M
2.38%
+27.86K
+0.59%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Langar Global HealthTech ETF
4.98%
VanEck Morningstar Wide Moat Value ETF
4.58%
Leatherback Long/Short Alternative Yield ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.46%
iShares U.S. Medical Devices ETF
2.37%
First Trust Indxx Medical Devices ETF
2.13%
American Century Focused Large Cap Value ETF
2.03%
Invesco Raymond James SB-1 Equity ETF
1.87%
First Trust Health Care Alphadex Fund
1.78%
State Street SPDR S&P Health Care Equipment ETF
1.75%
Ver más
Langar Global HealthTech ETF
Proporción4.98%
VanEck Morningstar Wide Moat Value ETF
Proporción4.58%
Leatherback Long/Short Alternative Yield ETF
Proporción2.9%
VanEck Morningstar Wide Moat ETF
Proporción2.46%
iShares U.S. Medical Devices ETF
Proporción2.37%
First Trust Indxx Medical Devices ETF
Proporción2.13%
American Century Focused Large Cap Value ETF
Proporción2.03%
Invesco Raymond James SB-1 Equity ETF
Proporción1.87%
First Trust Health Care Alphadex Fund
Proporción1.78%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.75%
Dividendos
Un total de
996.70M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Dec 17, 2025
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 30, 2026 going ex on Dec 30, 2025 with reinvestment option
Dec 30, 2025
Jan 30, 2026
Dec 30, 2025
Aug 27, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 30, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2025 going ex on Jun 26, 2025
Jun 26, 2025
Jul 31, 2025
Jun 26, 2025
Feb 26, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024 with reinvestment option
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Zimmer Biomet Holdings Inc?
Los cinco principales accionistas de Zimmer Biomet Holdings Inc son:
Dodge & Cox posee 22.10M acciones, lo que representa el 11.15% del total de acciones.
The Vanguard Group, Inc. posee 23.16M acciones, lo que representa el 11.69% del total de acciones.
T. Rowe Price Associates, Inc. posee 14.50M acciones, lo que representa el 7.32% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 10.93M acciones, lo que representa el 5.52% del total de acciones.
State Street Investment Management (US) posee 8.75M acciones, lo que representa el 4.42% del total de acciones.
Dodge & Cox posee 22.10M acciones, lo que representa el 11.15% del total de acciones.
The Vanguard Group, Inc. posee 23.16M acciones, lo que representa el 11.69% del total de acciones.
T. Rowe Price Associates, Inc. posee 14.50M acciones, lo que representa el 7.32% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 10.93M acciones, lo que representa el 5.52% del total de acciones.
State Street Investment Management (US) posee 8.75M acciones, lo que representa el 4.42% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Zimmer Biomet Holdings Inc?
Los tres principales tipos de accionista de Zimmer Biomet Holdings Inc son:
Dodge & Cox
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
Dodge & Cox
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
¿Cuántas instituciones poseen acciones de Zimmer Biomet Holdings Inc (ZBH)?
A fecha de 2025Q3, 1945 instituciones poseen acciones de Zimmer Biomet Holdings Inc, con un valor de mercado combinado de aproximadamente 195.45M, lo que representa el 98.66% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 2.44%.
¿Cuál es la mayor fuente de ganancias de Zimmer Biomet Holdings Inc?
El FY2025Q2, el segmento empresarial Knees generó la ganancia más alta para Zimmer Biomet Holdings Inc, ascendiendo a 826.00M y representando el 39.76% de la ganancia total.
